What is the clinical evidence from this study?

Study design: Review. Population: Acute Coronary Syndrome. Intervention: Cardiac biomarkers.

January 1, 2017AMEI's Current Trends in Diagnosis & TreatmentOpen Access

Cardiac Biomarkers in Acute Coronary Syndrome

View Full Paper

Ask AI

Bookmark

Key result

Cardiac troponins currently have the highest sensitivity and specificity for myocardial necrosis, representing the biochemical gold standard for diagnosing acute myocardial infarction.

Population

Patients with acute coronary syndrome (ACS) or acute myocardial infarction (AMI)

Design

Review

Authors

GMGurinder MohanGuru Nanak Dev University RKRanjeet KaurChandigarh University TSTrimaan Singh

Discussion

Member takes

Implication

Reinforces troponin as AMI diagnostic standard; confirms consensus yet leaves open novel biomarker validation.

Structured PICO

Population

Patients with acute coronary syndrome (ACS) or acute myocardial infarction (AMI)

Exposure

Cardiac biomarker testing (AST, LDH, CK, CK-MB, myoglobin, cardiac troponins)

This review summarizes the historical evolution of cardiac biomarkers, highlighting high-sensitivity cardiac troponins as the current gold standard for diagnosing acute myocardial infarction.

Cite This Study

Mohan et al. (2017) conducted a review in Acute Coronary Syndrome. Cardiac biomarkers was evaluated. Cardiac troponins currently have the highest sensitivity and specificity for myocardial necrosis, representing the biochemical gold standard for diagnosing acute myocardial infarction.

synapsesocial.com/papers/6a2020d28fbc0747110ddb30 https://doi.org/10.5005/jp-journals-10055-0019

View Full Paper

Ask AI

Bookmark

Cardiac Biomarkers in Acute Coronary Syndrome

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Cardiac Biomarkers in Acute Coronary Syndrome

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Also Consider